A regular internet blog written by Dr. Prodromos describing the latest advances in Stem Cell Medicine and related topics that you can use to help improve the health of yourself and your loved ones. (NOTE: your email address is kept strictly confidential)
Mesenchymal stem cells (MSCs) innately migrate toward areas of inflammation. Research shows that when administered intravenously, mesenchymal stem cells cross the blood-brain barrier leading to various therapeutic effects.
Stem cells are undifferentiated cells that can become multiple types of cells and reproduce continuously. There are two major types of stem cells: mesenchymal and embryonic. Mesenchymal stem cells have been shown potential to be useful in therapeutic procedures to treat diseases such as Alzheimer’s, kidney disease, cancer, and osteoarthritis. As stem cell therapy has become more popular and reliable, many myths and pieces of misinformation have arisen surrounding it.
Stem cells are undifferentiated cells which are defined by their ability to become multiple types of cells and their ability to proliferate indefinitely. Two of the most commonly talked about types of stem cells are mesenchymal and embryonic.
INTRODUCTION: Neurologic diseases are some of the most dreaded in existence. Like most human afflictions many of them involve inflammatory changes. For this reason stem cell treatment, which is anti-inflammatory, has shown excellent promise in treating a significant number of the most feared neurologic disorders. Often times immunosuppressive drugs are used for treatment. However these drugs have a high side effects profile. In contrast stem cell treatment has no significant side effects.
This is the title of a 2016 research paper published in the prestigious Journal of the American Heart Association. It can be found here. In their conclusions section discussing CVD (cardiovascular disease) they state “hydroxychloroquine use was associated with a 72% decrease in the risk of incident CVD in RA patients.”This is particularly important because heart disease is the leading cause of death in rheumatoid arthritis patients.
